Genmab | GEN - Ebitda





Ebitda Cambiamento Data
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Almirall EUR 114.07M 60.37M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
argenx SE USD 404.12M 17.08M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 4.45B 2.49B 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Demant DKK 2.76B 165M 2025-12
Exelixis USD 258.29M 15.43M 2026-03
Fresenius Medical Care EUR 824M 250M 2026-03
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GN Store Nord DKK 491M 136M 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Insmed USD -148.3M 165.88M 2026-03
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.53B 87M 2026-03
Novartis USD 5.3B 530M 2026-03
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
UCB EUR 1.6B 570M 2025-12